Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Ciba Vision and QLT PhotoTherapeutics seek approval for Visudyne in U.S., Switzerland

Aug. 19, 1999

InSite Vision licenses AquaSite to SSP in Japan

Aug. 18, 1999

Visudyne filed for marketing approval with EMEA

Aug. 11, 1999

Anecortave acetate: a novel angiostatic steroid for the treatment of ocular neovascular diseases

Aug. 4, 1999

Beta-blocker proxodolol, a safe and effective treatment for glaucoma

Aug. 4, 1999

Travoprost is safe and effective in treating elevated IOP in glaucoma patients

Aug. 3, 1999

Allergan profiles its Ocular Hypotensive Lipids at SOE 1999

Aug. 3, 1999

Alcon describes therapeutic potential of ocular antiinflammatory agents

Aug. 3, 1999

Acadia licenses novel leads for glaucoma therapy to Allergan

July 30, 1999

New muscarinic compounds from Alcon especially useful for Rx of glaucoma

July 29, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...